Universitätsklinikum Schleswig-Holstein (UKSH)

Factors associated with long-term survival after failure a chimeric antigen receptor (CAR) T cell therapy for relapsed or refractory large B-cell lymphomas:a role for allogeneic stem cell transplantation? (2022) Derigs P, Bethge W, Holtick U, Von Tresckow B, Ayuk F, Penack O, Vucinic V, et al. Conference contribution Immune Checkpoint Co-blockade of CD47 and HLA Class I Receptors to increase CD20 Antibody-mediated Phagocytosis of Lymphoma Cells (2022) Zeller T, Lutz S, Munnich IA, Windisch R, Hilger P, Herold T, Tahiri N, et al. Conference contribution Immunophenotypes and Targets of clonally expanded T Cells in the Bone Marrow of Patients with acquired Aplastic Anemia (2022) Ben Hamza A, Welters C, Bruggemann M, Dietze K, Bullinger L, Brummendorf TH, Winkler T, et al. Conference contribution Steigerung der zytotoxischen Aktivitat eines CD19 Antikorpers durch duale Fc-Optimierung (2022) Gehlert CL, Rahmati P, Boje AS, Winterberg D, Krohn S, Theocharis T, Nimmerjahn F, et al. Conference contribution VERTEBRAL FRACTURE AS RISK FACTOR FOR SUBSEQUENT VERTEBRAL FRACTURE: ICD-10 BASED ANALYSIS OF A REAL-WORLD DATABASE (2022) Glueer CC, Engelke K, Kistler M, Thomasius F, Hadji P, Schweikert B, Libanati C, Moayyeri A Conference contribution Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG (2022) Franklin C, Mohr P, Meier F, Weichenthal M, Grimmel-Mann I, Gutzmer R, Utikal JS, et al. Conference contribution Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG (2022) Franklin C, Mohr P, Bluhm L, Grimmelmann I, Gutzmer R, Meier F, Garzarolli M, et al. Conference contribution Real-world clinical outcomes of pembrolizumab for advanced melanoma in the German ADOREG skin cancer registry (2022) Mohr P, Scherrer E, Alar V, Assaf C, Beissert S, Berking C, Eigentler T, et al. Conference contribution Predictors of long-term survival of stage IV melanoma patients: a multicenter DeCOG study on 539 patients from the prospective skin cancer registry ADOREG (2022) Placke JM, Mohr P, Bluhm L, Kahler K, Weichenthal M, Meier F, Garzarolli M, et al. Conference contribution Therapy Management of the first Recurrence after adjuvant Therapy in Stage III: multicenter real-world Data (2022) Lodde G, Forschner A, Hassel JC, Wulfken LM, Meier F, Mohr P, Kaehler K, et al. Conference contribution